wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-3C4F9B28-4012-43C3-8011-2C9B9290201A
Q38404422-3C4F9B28-4012-43C3-8011-2C9B9290201A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-3C4F9B28-4012-43C3-8011-2C9B9290201A
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-3C4F9B28-4012-43C3-8011-2C9B9290201A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-3C4F9B28-4012-43C3-8011-2C9B9290201A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.